GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (STU:R5XA) » Definitions » Future Policy Benefits

Talphera (STU:R5XA) Future Policy Benefits


View and export this data going back to 2014. Start your Free Trial

What is Talphera Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Talphera (STU:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.